Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7000
+0.0200 (1.19%)
NASDAQ · Last Trade: Jan 14th, 6:20 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors